is again at the top of the list and semaglutide (Ozempic® and Wegovy®) from Novo Nordisk retains its top 5 position. New to the list is tirzepatide (Mounjaro® and Zepbound®) from Lilly at No ...

Vizient, Inc. released its new Spend Management Outlook representing the best estimate of the change in the price of pharmaceuticals, medical devices and supplies, capital equipment and services ...

Global Healthy Living Foundation Says Hims & Hers Health Super Bowl ad omits safety risks and side effects of its weight loss ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

The newest weight-loss drugs, Wegovy and Zepbound ... the FDA also added to Zepbound’s label that it can reduce the symptoms of obstructive sleep apnea. Other health benefits, including the ...

During that time, Social Security retirement benefits have also experienced a change. In 2005, the average monthly Social Security benefit was $1,002, or just over $12,000 annually. To start this ...

Personal Finance. Chapter 35 VA Benefits 2025: How much is the maximum you receive for education this year? Personal Finance. Chapter 36 VA Benefits: Who is eligible for educational and career ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

You must be at least 61 years and 9 months, and want your benefits to start in no more than 4 months. Apply at www.ssa.gov/retirement. Need a break? Play the USA ...

“Now we are rolling back these DEI initiatives without recognizing that so many top-tier employees and talent were drawn to the company because of these benefits,” Lickstein said. Women have ...